CRH Medical Corp (NASDAQ:CRHM) shares saw strong trading volume on Wednesday . 201,980 shares were traded during mid-day trading, an increase of 68% from the previous session’s volume of 120,312 shares.The stock last traded at $3.80 and had previously closed at $3.85.

A number of analysts recently weighed in on the company. Canaccord Genuity restated a “buy” rating on shares of CRH Medical Corp in a report on Thursday, June 16th. Zacks Investment Research upgraded CRH Medical Corp from a “hold” rating to a “buy” rating and set a $3.75 price objective for the company in a report on Monday, June 6th.

The firm’s 50 day moving average price is $3.14 and its 200-day moving average price is $2.95.

CRH Medical Corporation, formerly Medsurge Medical Products Corp., is a healthcare products and services company. The Company operates through segments, including the sale of medical products and the provision of anesthesia services. The Company specializes in the treatment of hemorrhoids utilizing its treatment protocol and technology.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.